• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌根治性切除术后腺瘤的发生率。

Incidence of adenomas after curative resection for colorectal cancer.

作者信息

Neugut A I, Lautenbach E, Abi-Rached B, Forde K A

机构信息

Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York, USA.

出版信息

Am J Gastroenterol. 1996 Oct;91(10):2096-8.

PMID:8855728
Abstract

OBJECTIVE

The benefits of periodic colonoscopic surveillance after curative resection for colon cancer are controversial. We investigated the incidence, size, and time interval to the detection of recurrent adenomatous polyps in patients who have undergone resection of a colorectal cancer.

METHODS

In this retrospective study, the records of 351 patients who underwent curative resection for colorectal carcinoma between 1967 and 1991 were reviewed. Sixty-one patients were excluded because of incomplete data.

RESULTS

Eighty-seven patients (30%) were found to have had at least one adenoma. Twelve patients had more than five adenomas. The median time to diagnosis was 24 months. Forty-six patients of the 87 (52.9%) had polyp recurrences within 2 yr after cancer resection.

CONCLUSION

This group of patients is at increased risk for the development of adenomatous polyps. Surveillance colonoscopy and polypectomy may reduce the incidence of metachronous colon cancer.

摘要

目的

结肠癌根治性切除术后定期进行结肠镜监测的益处存在争议。我们调查了接受结直肠癌切除的患者中复发性腺瘤性息肉的发生率、大小及检测的时间间隔。

方法

在这项回顾性研究中,我们回顾了1967年至1991年间351例行结直肠癌根治性切除患者的记录。61例患者因数据不完整被排除。

结果

87例患者(30%)被发现至少有一个腺瘤。12例患者有五个以上腺瘤。诊断的中位时间为24个月。87例患者中有46例(52.9%)在癌症切除后2年内出现息肉复发。

结论

该组患者发生腺瘤性息肉的风险增加。监测性结肠镜检查及息肉切除术可能会降低异时性结肠癌的发生率。

相似文献

1
Incidence of adenomas after curative resection for colorectal cancer.结直肠癌根治性切除术后腺瘤的发生率。
Am J Gastroenterol. 1996 Oct;91(10):2096-8.
2
Increased incidence of colorectal adenomas in follow-up evaluation of patients with newly diagnosed hyperplastic polyps.新诊断增生性息肉患者随访评估中结直肠腺瘤发病率增加。
Surg Endosc. 2001 Jul;15(7):646-8. doi: 10.1007/s004640000389. Epub 2001 May 14.
3
Endoscopic follow-up in resected colorectal cancer patients.接受结直肠癌切除术患者的内镜随访
J Exp Clin Cancer Res. 2000 Jun;19(2):145-8.
4
Metachronous colon cancer in persons who have had a large adenomatous polyp.
Am J Gastroenterol. 1996 Mar;91(3):448-54.
5
Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.结肠镜息肉切除术预防结直肠癌。国家息肉研究工作组。
N Engl J Med. 1993 Dec 30;329(27):1977-81. doi: 10.1056/NEJM199312303292701.
6
[The role of colonoscopy in early diagnosis of intraluminal recurrences in patients already treated for colorectal cancer].[结肠镜检查在已接受结直肠癌治疗患者腔内复发早期诊断中的作用]
Minerva Chir. 1996 Nov;51(11):911-8.
7
Colonoscopy: a review of its yield for cancers and adenomas by indication.结肠镜检查:按适应证对其癌症和腺瘤检出率的综述。
Am J Gastroenterol. 1995 Mar;90(3):353-65.
8
A normal initial colonoscopy after age 50 does not predict a polyp-free status for life.50岁之后首次结肠镜检查结果正常并不能预测一生都不会出现息肉。
Am J Gastroenterol. 1994 Aug;89(8):1156-9.
9
High compliance rates observed for follow up colonoscopy post polypectomy are achievable outside of clinical trials: efficacy of polypectomy is not reduced by low compliance for follow up.在临床试验之外,息肉切除术后随访结肠镜检查也可实现高依从率:随访低依从性不会降低息肉切除术的疗效。
Colorectal Dis. 2004 May;6(3):158-61. doi: 10.1111/j.1463-1318.2004.00585.x.
10
Colonoscopy surveillance after polypectomy and colorectal cancer resection.息肉切除和结直肠癌切除术后的结肠镜监测
Am Fam Physician. 2008 Apr 1;77(7):995-1002.

引用本文的文献

1
Does Colonic Diverticulosis Raise the Risk of Colorectal Adenoma in Patients with Colorectal Cancer?结肠憩室病会增加结直肠癌患者患大肠腺瘤的风险吗?
Gastroenterol Res Pract. 2019 May 20;2019:8901026. doi: 10.1155/2019/8901026. eCollection 2019.
2
Targeting colorectal cancer stem cells using curcumin and curcumin analogues: insights into the mechanism of the therapeutic efficacy.使用姜黄素及其类似物靶向结直肠癌干细胞:对治疗效果机制的见解
Cancer Cell Int. 2015 Oct 9;15:96. doi: 10.1186/s12935-015-0241-x. eCollection 2015.
3
Natural history and long-term outcomes of patients treated for early stage colorectal cancer.
早期结直肠癌患者的自然病史及长期预后
Can J Gastroenterol. 2013 Jul;27(7):409-13. doi: 10.1155/2013/920689.
4
Strategies to evaluate synchronous carcinomas of the colon and rectum in patients that present for emergent surgery.针对需进行急诊手术的患者,评估其结肠和直肠癌同步癌的策略。
Int J Surg Oncol. 2013;2013:309439. doi: 10.1155/2013/309439. Epub 2013 Feb 6.
5
Factors affecting colonoscope insertion time in patients with or without a colostomy after left-sided colorectal resection.影响左半结直肠切除术后有或无结肠造口患者结肠镜插入时间的因素。
Dig Dis Sci. 2012 Dec;57(12):3219-25. doi: 10.1007/s10620-012-2257-6. Epub 2012 Jun 8.
6
Combination of dasatinib and curcumin eliminates chemo-resistant colon cancer cells.达沙替尼与姜黄素联合使用可消除化疗耐药的结肠癌细胞。
J Mol Signal. 2011 Jul 20;6:7. doi: 10.1186/1750-2187-6-7.
7
Factors affecting insertion time for colonoscopy performed under intramuscular analgesia in patients with history of colorectal resection.影响有结直肠切除史患者行肌内镇痛下结肠镜插入时间的因素。
Surg Endosc. 2011 Jul;25(7):2316-22. doi: 10.1007/s00464-010-1555-3. Epub 2011 Feb 7.
8
Estimating the unknown parameters of the natural history of metachronous colorectal cancer using discrete-event simulation.使用离散事件模拟估计结直肠异时癌自然史的未知参数。
Med Decis Making. 2011 Jul-Aug;31(4):611-24. doi: 10.1177/0272989X10391809. Epub 2011 Jan 6.
9
Difluorinated-curcumin (CDF): a novel curcumin analog is a potent inhibitor of colon cancer stem-like cells.二氟二氢姜黄素(CDF):一种新型姜黄素类似物,是一种有效的结肠癌干细胞样细胞抑制剂。
Pharm Res. 2011 Apr;28(4):827-38. doi: 10.1007/s11095-010-0336-y. Epub 2010 Dec 14.
10
Synergistic role of curcumin with current therapeutics in colorectal cancer: minireview.姜黄素与当前疗法联合治疗结直肠癌的协同作用:综述。
Nutr Cancer. 2009;61(6):842-6. doi: 10.1080/01635580903285106.